Inovio Pharmaceuticals Inc
NASDAQ:INO

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
NASDAQ:INO
Watchlist
Price: 1.31 USD -3.68% Market Closed
Market Cap: 48m USD

Wall Street
Price Targets

INO Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast INO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INO is 8.16 USD with a low forecast of 2.02 USD and a high forecast of 13.65 USD.

Lowest
Price Target
2.02 USD
54% Upside
Average
Price Target
8.16 USD
523% Upside
Highest
Price Target
13.65 USD
942% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
600161
Beijing Tiantan Biological Products Corp Ltd
54% Upside
251120
Bio-FD&C Co Ltd
8% Upside
TGTX
TG Therapeutics Inc
14% Upside
KALV
Kalvista Pharmaceuticals Inc
83% Upside
BBIO
BridgeBio Pharma Inc
31% Upside
QURE
Uniqure NV
165% Upside
6955
Shandong Boan Biotechnology Co Ltd
39% Downside
DTIL
Precision BioSciences Inc
393% Upside

Revenue
Forecast

Revenue Estimate
Inovio Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Inovio Pharmaceuticals Inc's revenue is -47%. The projected CAGR for the next 3 years is 598%.

-47%
Past Growth
598%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Inovio Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Inovio Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INO's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for INO is 8.16 USD with a low forecast of 2.02 USD and a high forecast of 13.65 USD.

What is Inovio Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
598%

For the last 8 years the compound annual growth rate for Inovio Pharmaceuticals Inc's revenue is -47%. The projected CAGR for the next 3 years is 598%.

Back to Top